These findings showed that CRP levels are influenced by BMI and Alistipes, particularly in lupus individuals with higher BMI and highlight the need for personalized approaches based on body composition, inflammatory markers and gut microbiota in patients with lupus and obesity for improving clinical management and outcomes. The gene discussed is CRP; the disease is obesity due to melanocortin 4 receptor deficiency.